MedPath
Found 1 clinical trials|View Analysis
Sort by:

Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT

Recruiting
Conditions
Letemovir for the Prevention of CMV Infection After Allo-HSCT
Interventions
First Posted Date
2024-03-12
Last Posted Date
2024-03-12
Lead Sponsor
Cao Weijie
Target Recruit Count
150
Registration Number
NCT06306989
Locations
🇨🇳

Cao, Weijie, Zhengzhou, Henan, China

© Copyright 2025. All Rights Reserved by MedPath